- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06102850
Adaptation of Critical Time Intervention for Young Adults With MH Challenges (CTI-YAMH)
Adaptation of Critical Time Intervention for Young Adults With Mental Health Challenges in the Transition From Homelessness to Housing
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The design of the phased open trial allows for us to test and further refine our intervention procedures, then include this learning in a randomized feasibility pilot. This will enable us to examine several issues that we anticipate will need refinement prior to larger testing in a fully powered future large study. Our sample (n=60) will include young adults (age 18-24) who have qualified for RRH supports. Entry into the homelessness system is managed through a coordinated access system with a consistent assessment process and centralized wait list which is prioritized based on a screener that asks respondents to self-report whether they have been diagnosed with a mental disorder. Young adults are assigned to a RRH case manager based on capacity across agencies that provide RRH including Covenant House TExas (CHT). CTI-YAMH targets young adults with mental health symptoms and will be implemented at CHT. The screening tool used to prioritize assignment to housing asks for a self-report of mental health symptoms as well as other risk factors that give a housing priority score. When CHT has capacity for a new youth, we will work with the coordinated access system to match and enroll two young adults with similar priority scores into our study after screening for mental health symptoms, then randomize one to CHT and one to another agency providing young adult RRH with capacity (TAU). We will closely track the feasibility of this real-world process, keeping track of the number of YAEH who are on the waiting list, number contacted, number successfully enrolled, and number that meet our enrollment criteria. For this study, we will partner with CHT which currently employs three RRH case managers who each carry a caseload of 18 young adults.
For the first phase of the open trial, we aim to recruit and enroll a sample of 8 participants. We anticipate this will take approximately 3 months which will enable us to refine our enrollment procedures and finalize intervention procedures. After 6 months we will move into the next phase. For the second phase of the open trial, we aim to recruit a sample of 52 young adults, 26 for each condition over the course of the 12-month period. Across the community, the average length of stay in RRH is 12 months so without accounting for likely expansion, we anticipate that there will be approximately 4-5 intakes per month for the CHT RRH program at current size. Given the new focus on young adults in the community and potential expansion of RRH services at CHT, we expect that this number will increase as services ramp up. Based on our prior research, we estimate that 60-75% will screen positive for mental health problems as assessed with the Kessler-6 so at current capacity we would identify 3-4 participants per month that are eligible for the study and enroll 2-3 of these for approximately 12 months in the intervention condition and 2-3 participants per month for 12 months in the TAU condition..condition.
Enrollment and Data Collection Procedures. For both phases, young adults (age 18-24) on the housing eligibility list will be screened for study criteria (meeting criteria for psychological distress on Kessler-6 [74] or self-reported prior diagnosis of depression, anxiety, bipolar or a psychotic disorder with ongoing symptoms) and invited to participate at the point of assignment to RRH. Young adults will be told of the opportunity to participate in the study at the time of eligibility assessment for housing and asked for permission to provide their names to the study team if interested. For the first phase we will attempt to enroll all those assigned to RRH at CHT who meet our criteria. For the second phase, when housing is about to be assigned for CHT, we will attempt to enroll two similar young people and assign one to CHT and one to TAU. For both phases 1 and 2, we will contact young people about their interest, then schedule a baseline interview to be held over zoom or by phone lasting approximately one hour. Interviewers will obtain informed consent electronically signed through DocuSign and administer the survey via phone or zoom with each meeting lasting approximately one hour. This format enables us to be flexible and responsive in scheduling interviews. If participants do not have access to a phone or zoom, researchers have the ability to meet clients in the agency where they individual is connected to a case manager. In order to track outcomes through the course of the 6-month intervention, research assistants we will administer surveys at baseline, the midpoint (3 months), end of the intervention (6 months) and 6 month6-month follow-up (12 months). Survey data at each measurement point will be collected on tablets using a questionnaire programmed in Qualtrics. For those in phase 1, we will also conduct qualitative interviews (n=8) and will also interview each of the professionals involved in implementing it (n=5) to explore qualitatively how the intervention activities hit the hypothesized targets of the intervention and allow the potential for other key mechanisms to emerge as well as assess implementation outcomes of acceptability and appropriateness. Qualitative interviews will be conducted using a semi-structured interview guide and will be digitally recorded, then transcribed. If participants do not want to be recorded, detailed notes will be taken.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alicia Vargas
- Phone Number: 713-743-9215
- Email: avargas2@uh.edu
Study Contact Backup
- Name: Yadira Cortez
- Phone Number: 713-743-5571
- Email: ycortez2@central.uh.edu
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77006
- Recruiting
- Covenant House Texas
-
Contact:
- Alan Prince, MPA
- Phone Number: 713-523-2231
- Email: aprince@covenanthouse.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Young adults (age 18-24) on the housing eligibility list assigned to rapid rehousing
- Positive for psychological distress on Kessler-6 or self-reported prior diagnosis of depression, anxiety, bipolar or a psychotic disorder with ongoing symptoms
Exclusion Criteria:
- Age 25 or older
- Not English speaking
- No eligible for rapid rehousing based on housing priority score
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Condition, CTI-YAMH
Participants receive the CTI-YAMH intervention in conjunction with rapid rehousing supports for the 6 month intervention
|
SIx month supportive intervention involving CTI phased based casemanagement, support from a peer support specialist, and support from a mental health liaison
|
|
No Intervention: Treatment as Usual Condition
Participants will be assigned to a housing program at another agency that provides rapid rehousing with usual supports
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Housing Stability
Time Frame: Baseline, 3 mo, 6 mo, 12 mo
|
Housing Security Scale Number of days homeless, Number of moves in prior 90 days
|
Baseline, 3 mo, 6 mo, 12 mo
|
|
Mental Disorder
Time Frame: Baseline, 12 mo.
|
Diagnosis of Common Disorders i.e.
Depression, Anxiety, Bipolar, Psychotic Disorders
|
Baseline, 12 mo.
|
|
Depressive Symptoms
Time Frame: Baseline, 3 mo, 6mo, 12 mo.
|
PHQ-9
|
Baseline, 3 mo, 6mo, 12 mo.
|
|
Anxiety Symptoms
Time Frame: Baseline, 3 mo, 6mo, 12 mo.
|
GAD-7
|
Baseline, 3 mo, 6mo, 12 mo.
|
|
PTSD Symptoms
Time Frame: Baseline, 3 mo, 6mo, 12 mo.
|
Primary Care PTSD Screen
|
Baseline, 3 mo, 6mo, 12 mo.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment Engagement
Time Frame: Baseline, 3 mo, 6mo, 12 mo.
|
Self-report of taking medication, attending appointments; Client Engagement in Child Protective Services Scale, modified for mental health services |
Baseline, 3 mo, 6mo, 12 mo.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R34MH129542-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorder
-
Vincent AgyapongNova Scotia Health Authority; Dalhousie UniversityRecruitingGeneralized Anxiety Disorder | Major Depressive Disorder | Mental Health Wellness 1Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Major Depressive Disorder | Mental Disorder | Bipolar I DisorderUnited States
-
Brigham and Women's HospitalActive, not recruitingDepression | Mood Disorders | Depressive Disorder, Major | Psychiatric Disorder | Mental DisorderUnited States
-
Queen's UniversityCompleted
-
University of ManchesterRecruitingADHD | Mental Health | Autism | Neurodevelopment | Depression - Major Depressive Disorder | Anxiety Disorder (Panic Disorder or GAD)United Kingdom
-
Samsung Medical CenterUnknownMajor Depressive Disorder, Anxiety DisorderKorea, Republic of
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
University of OuluCompletedSeasonal Affective Disorder (SAD)Finland
-
Massachusetts General HospitalSamsung ElectronicsActive, not recruitingMood Disorders | Major Depressive Disorder | Mental Health IssueUnited States
-
University of ChicagoUsona InstituteCompletedMajor Depressive Disorder | Borderline Personality DisorderUnited States
Clinical Trials on Critical Time Intervention for Young Adults with Mental Health conditions
-
University of California, San DiegoRecruitingObesity | Diabetes | Schizophrenia | Serious Mental Illness | Lifestyle Risk ReductionUnited States
-
Colliga Apps Corp.National Institute of Mental Health (NIMH)CompletedFamily Functioning | Mental Health and Well-beingUnited States
-
Columbia UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Psychiatric Research Unit, Region Zealand, DenmarkWithdrawnPsychiatric Hospitalization
-
University of Cape TownParenting for Lifelong Health; Mikhulu Trust; Clowns Without Borders South Africa and other collaboratorsNot yet recruitingChild MaltreatmentZimbabwe
-
Mayo ClinicEnrolling by invitationPancreatic CarcinomaUnited States